Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,391.97
(
-0.12%
)
US TECH 100
28,248.00
(
-0.15%
)
Dow Jones
49,526.49
(
-0.47%
)
Brent Oil
105.82
(
0.05%
)
Bitcoin
79,702.60
(
-0.98%
)
News Focus
News Focus
Post# of 447908
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

TastyTheElf

Send PM Follow Ignore
Followers 75
Posts 7728
Boards Moderated 0
Alias Born 05/01/2011

TastyTheElf

Re: Tseven post# 444615

Wednesday, 01/14/2026 11:05:24 AM

Wednesday, January 14, 2026 11:05:24 AM

Post# of 447908
That is true about the bear market in small biotech. Last year there was a near complete exodus of VCs putting money into the sector.

It set off a slew of bankruptcies, and as you said, those who still had cash were trading at a discount to it.

Amarin isn't really a "biotech" any more -- it's not developing anything, it's just managing the runoff of an approved drug. But still.

"The biggest obstacles to our progress exist within our own lives in the form of cowardice and the tendency to give up. Breaking through these barriers will unleash a surging wave of change." -- Daisaku Ikeda

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News